MedTrace Logo

Evolution® Biliary Stent System-Fully Covered

NCT02104076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-07-05

No results posted yet for this study

Summary

The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered when used in palliation of malignant neoplasms in the biliary tree.

Conditions

  • Carcinomas/Neoplasms

Interventions

DEVICE

Evolution® Biliary Stent-Fully Covered

Implantation of the Evolution® Biliary Stent-Fully Covered in the common bile duct utilizing ERCP

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Raj Shah, M.D. · University of Colorado, Denver

  • Marco Bruno, M.D. · Erasmus Medish Centrum

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-07-31
Completion
2017-01-04

Countries

  • United States
  • Canada
  • France
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104076 on ClinicalTrials.gov